If you strip out:
- revaluation increment
- depreciation
- amortisation
- 325k cash NR deposit
- tax benefit
And include cash finance expenses,
FY 17 loss is circa $2.55million.
It would be great to see the balance sheet strengthen over the next 24 months. The terms on the NeolCP loan will force this to happen to some extent.
Management are doing an exceptional job. This is a very well run business. 3-5 years required (Peter Lynch style).
- Forums
- ASX - By Stock
- STL
- News: STL Stargroup posts FY NPAT of $1.9 million
News: STL Stargroup posts FY NPAT of $1.9 million, page-10
-
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add STL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online